Related Experiment Video
Updated: Sep 13, 2025
07:36
Intra-Omental Islet Transplantation Using h-Omental Matrix Islet filliNG hOMING
Published on: March 14, 2019
7.1K
Rat Islet pECM Hydrogel-Based Microencapsulation: A Protective Niche for Xenotransplantation
Michal Skitel Moshe1,2, Stasia Krishtul1, Anastasia Brandis1
1Faculty of Biotechnology & Food Engineering, Technion-Israel Institute of Technology, Haifa 3200003, Israel.
Gels (Basel, Switzerland)
|July 25, 2025
Summary
This study developed new microcapsules from decellularized pig pancreas (pECM) to protect transplanted islets for type 1 diabetes (T1D) treatment. These pECM capsules improved islet survival and function, offering a promising path for cell-based diabetes therapy.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Endocrinology
Background:
- Type 1 diabetes (T1D) results from autoimmune destruction of pancreatic beta cells, leading to insulin deficiency.
- Islet transplantation is a potential therapy but faces challenges like donor scarcity and immune rejection.
- Current encapsulation methods have limitations in providing a supportive microenvironment for transplanted cells.
Purpose of the Study:
- To engineer novel, bioactive, and immunoprotective microcapsules using decellularized porcine pancreatic extracellular matrix (pECM) for islet encapsulation.
- To evaluate the efficacy of pECM-based microcapsules compared to traditional alginate microcapsules for islet transplantation.
- To assess the biocompatibility and therapeutic potential of pECM microencapsulation in a preclinical setting.
Main Methods:
- Rat islets were encapsulated into pECM microcapsules using electrospray technology.
- pECM and alginate microcapsules were compared for islet viability, function, and response to hypoxic stress.
- In vivo transplantation studies were conducted in immunocompetent mice to assess biocompatibility and immune response.
Main Results:
- pECM microcapsules maintained islet structural integrity, viability, and superior insulin secretion compared to alginate controls.
- Key beta-cell markers (PDX1, MAFA) and overall islet structure were preserved within pECM microcapsules.
- pECM encapsulation significantly reduced apoptosis under hypoxia, enhanced functional recovery, and demonstrated excellent biocompatibility in vivo with minimal immune reactions.
Conclusions:
- Decellularized porcine pancreatic extracellular matrix (pECM) is a suitable biomaterial for creating bioactive, immunoprotective microcapsules for islet encapsulation.
- pECM-based microencapsulation offers a promising strategy to overcome immune rejection and improve outcomes in xenogeneic islet transplantation for type 1 diabetes.
- This innovative approach holds potential for advancing cell-based therapies for diabetes management.
